Anti-CD38 antibodies and pharmaceutical compositions thereof for the treatment of autoantibody-mediated autoimmune disease
TW202631198APending Publication Date: 2026-08-01MORFOZIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2020-03-13
- Publication Date
- 2026-08-01
Smart Images
Figure 00000000_0000_ABST
Abstract
The present invention relates to the use of an antibody or antibody fragment specific for CD38 in the prophylaxis and / or treatment of autoantibody-mediated autoimmune disease. In accordance with the present invention, an anti-CD38 antibody is effective in the treatment of anti-PLA2R positive membranous glomerulonephropathy.
Need to check novelty before this filing date? Find Prior Art